HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.

AbstractBACKGROUND:
Papillary thyroid carcinoma (PTC) is often accompanied by lymph node metastasis (LNM), compared with follicular thyroid carcinoma (FTC). Sialic acid is carried by fibronectin (sFN) as the antigen of monoclonal antibody (MoAb) JT-95 detected in 90% of PTC, and a few cases of FTC.
PATIENTS AND METHODS:
JT-95 staining was performed in 9 PTC and 20 follicular type tumors to investigate the relationship between the expression of sFN and the frequency of LNM.
RESULTS:
There were 11 cases with LNM from 23 malignant tumors, and no cases of LNM from 6 benign follicular type tumors. The staining scores by JT-95 of the 11 tumors with LNM were 5+ in 4 cases, and 6+ in 7 cases. On the other hand, the scores of 12 malignant tumors without LNM were <4+ in all cases.
CONCLUSION:
An increase of sFN expression in thyroid malignancies is correlated with LNM.
AuthorsHiroshi Takeyama, Shigeya Kyoda, Tomoyoshi Okamoto, Yoshinobu Manome, Michiko Watanabe, Satoki Kinoshita, Ken Uchida, Atsuhiko Sakamoto, Toshiaki Morikawa
JournalAnticancer research (Anticancer Res) Vol. 31 Issue 4 Pg. 1395-8 (Apr 2011) ISSN: 1791-7530 [Electronic] Greece
PMID21508391 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Fibronectins
  • N-Acetylneuraminic Acid
Topics
  • Adenocarcinoma, Follicular (immunology, metabolism, secondary)
  • Adult
  • Antibodies, Monoclonal (immunology, metabolism)
  • Carcinoma, Papillary (immunology, metabolism, secondary)
  • Female
  • Fibronectins (immunology, metabolism)
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • N-Acetylneuraminic Acid (immunology, metabolism)
  • Prognosis
  • Thyroid Neoplasms (immunology, metabolism, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: